News
GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...
The increase was driven by rising use of Mounjaro, or tirzepatide, which has been dubbed the “King Kong” of weight loss jabs.
1d
HealthShots on MSNMounjaro side effects: 10 common and long-term reactions you shouldn’t ignoreMounjaro, one of the brand names for tirzepatide, is a drug that is beneficial for people with type 2 diabetes. This ...
The Mounjaro 'golden dose' has been explained after doctors issued an urgent warning over the potential deadly hack.
Human insulin presents Indian companies an opportunity estimated at Rs 450 crore per annum in India and $157 million/annum in emerging markets.
Doctors have issued an urgent warning over the 'golden dose' hack for Mounjaro as it could be fatal. According to a recent ...
The Medicines and Healthcare Products Regulatory Agency has issued new guidance to women taking weight-loss injections, such ...
Meanwhile, the MHRA has also warned all people seeking treatment with the so-called "skinny jabs" to beware of counterfeit ...
Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...
Camurus licensed its FluidCrystal drug delivery tech to Eli Lilly for global development of long-acting incretin therapies ...
The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results